BBC News5h agoHealth
UK Regulator Approves Human Trials for New Ebola Vaccine Developed by Oxford University
Quick Look
- Human trials for a new Ebola vaccine, developed by Oxford University using technology similar to the COVID-19 vaccine, have been approved by UK regulators.
- The vaccine targets the Bundibugyo species of Ebola, responsible for an ongoing epidemic in the Democratic Republic of the Congo.
AI-generated summary
Font size
Human trials for a new Ebola vaccine, developed by Oxford University using technology similar to the COVID-19 vaccine, have been approved by UK regulators. The vaccine targets the Bundibugyo species of Ebola, responsible for an ongoing epidemic in the Democratic Republic of the Congo.
Related Topics
This article was originally published by BBC News.
